Alcami Names New CEO

Alcami, a U.S.-based contract development and manufacturing organization (CDMO), has appointed Walter J. Kaczmarek III as chief executive officer. Mr. Kaczmarek, who has over 30 years of experience in the pharmaceutical industry, will focus on advancing Alcami's next phase of strategic growth.

Mr. Kaczmarek has served in executive roles at multiple pharmaceutical companies, including as president of the Multisource Pharmaceuticals division of Mallinckrodt Pharmaceuticals, chief operating officer of Aceto Corporation, and most recently, as president and chief executive officer of Cosette Pharmaceuticals. Mr. Kaczmarek is an industry veteran with a depth of experience spanning the entire value chain from development and manufacturing to sales and marketing.
"Walt's track record of consistently leading pharmaceutical businesses to achieve high levels of growth makes him the ideal executive to advance Alcami forward,” said Harry Kraemer, chairman of the board, Alcami. “Walt's core skills of business development, relationship-building, and leading high performing teams will contribute significantly to Alcami and our goal of building it into the preferred provider of pharmaceutical services."